Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination

NCT00291954 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y

NCT00698061 ·Status: COMPLETED ·Phase: PHASE3

Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population

NCT03962881 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

NCT00508833 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

NCT00480116 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine

NCT01951677 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype

NCT00697749 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients

NCT00186836 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

NCT00697216 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease

NCT01282762 ·Status: COMPLETED

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

NCT00697853 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients

NCT01933412 ·Status: UNKNOWN ·Phase: PHASE3

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

NCT00696891 ·Status: COMPLETED ·Phase: PHASE3

Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients

NCT01468051 ·Status: COMPLETED ·Phase: NA

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

NCT00291941 ·Status: COMPLETED ·Phase: PHASE3

Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients

NCT00985426 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age

NCT00697554 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients

NCT02963714 ·Status: COMPLETED ·Phase: PHASE4

Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control

NCT00697866 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

NCT00197158 ·Status: COMPLETED ·Phase: PHASE4

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B

NCT00697840 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

NCT00697125 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults

NCT06989788 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B

NCT02901951 ·Status: COMPLETED ·Phase: PHASE4

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01037114 ·Status: COMPLETED ·Phase: PHASE4